Yves Cohen
Corporate Officer/Principal bei Geneva Financial Services Sàrl
Profil
Yves Cohen founded Inoks Capital Management and Point Clear Capital Management LLC.
Mr. Cohen also currently works at Geneva Financial Services Sàrl, as Managing Director from 2012.
Mr. Cohen also formerly worked at ViRexx Medical Corp., as Director and Bluewater Bio Ltd., as Non-Executive Director.
Mr. Cohen received his graduate degree from the University of Geneva.
Aktive Positionen von Yves Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| Geneva Financial Services Sàrl | Corporate Officer/Principal | - |
| Inoks Capital Management | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Yves Cohen
| Unternehmen | Position | Ende |
|---|---|---|
ViRexx Medical Corp.
 ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | 14.09.2008 |
| Point Clear Capital Management LLC | Gründer | - |
Bluewater Bio Ltd.
 Bluewater Bio Ltd. Environmental ServicesIndustrial Services Bluewater Bio Ltd. is a holding company, which provides wastewater treatment services. Its technologies include HYBACS, FilterClear, Neo Tech, CFIC and GHG-Tox. The firm also provides operational and maintenance services. The company operates through its offices located in Kirkintilloch, Gauteng, Cape Town and Saudi Arabia. Bluewater Bio was founded by Daniel Ishag and Adrian Harris in 2007 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yves Cohen
| University of Geneva | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
Bluewater Bio Ltd.
Bluewater Bio Ltd. Environmental ServicesIndustrial Services Bluewater Bio Ltd. is a holding company, which provides wastewater treatment services. Its technologies include HYBACS, FilterClear, Neo Tech, CFIC and GHG-Tox. The firm also provides operational and maintenance services. The company operates through its offices located in Kirkintilloch, Gauteng, Cape Town and Saudi Arabia. Bluewater Bio was founded by Daniel Ishag and Adrian Harris in 2007 and is headquartered in London, the United Kingdom. | Industrial Services |
| Geneva Financial Services Sàrl | |
| Inoks Capital Management | |
| Point Clear Capital Management LLC |
